Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Debt to Equity: 2014-2024

Historic Debt to Equity for Surgery Partners (SGRY) over the last 10 years, with FY2024 value amounting to $1.05.

  • Surgery Partners' Debt to Equity rose 1058.94% to $1.13 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.13, marking a year-over-year increase of 1058.94%. This contributed to the annual value of $1.05 for FY2024, which is 1529.65% up from last year.
  • As of FY2024, Surgery Partners' Debt to Equity stood at $1.05, which was up 1529.65% from $0.91 recorded in FY2023.
  • Surgery Partners' Debt to Equity's 5-year high stood at $3.24 during FY2020, with a 5-year trough of $0.89 in FY2022.
  • Moreover, its 5-year median value for Debt to Equity was $1.05 (2024), whereas its average is $1.52.
  • Its Debt to Equity has fluctuated over the past 5 years, first surged by 2341.12% in 2020, then tumbled by 5392.88% in 2021.
  • Surgery Partners' Debt to Equity (Annual) stood at $3.24 in 2020, then tumbled by 53.93% to $1.49 in 2021, then plummeted by 40.25% to $0.89 in 2022, then grew by 2.58% to $0.91 in 2023, then grew by 15.3% to $1.05 in 2024.
  • Its last three reported values are $1.05 in FY2024, $0.91 for FY2023, and $0.89 during FY2022.